Trigger Point Injection and Myofascial Release for Cervicogenic Headache

Cervicogenic headache is a type of headache associated with problems in the neck. This study aims to compare the effects of trigger point injection, myofascial release, and their combination in patients with cervicogenic headache. A total of 120 adults aged 18-65 years with cervicogenic headache are planned to be included and randomly assigned to one of four groups: trigger point injection with home exercises, myofascial release with home exercises, combined trigger point injection and myofascial release with home exercises, or home exercises alone. Trigger point injections will be performed using 0.5% lidocaine once weekly for four sessions. Myofascial release will also be provided once weekly for four sessions in the relevant groups. The home exercise program will include neck range-of-motion exercises, stretching, and is

Inclusion Criteria: * Adults aged 18-65 years. * Neck pain or headache for at least 3 months. * Fulfillment of the study's clinical criteria for cervicogenic headache: * Unilateral pain. * Reduced cervical range of motion. * Ipsilateral shoulder discomfort. * Ipsilateral arm discomfort. * Pain exacerbated by different neck movements and pain on palpation. Exclusion Criteria: * Migraine. * Cluster headache. * Cervical radiculopathy. * Entrapment neuropathy. * Myelopathy. * Rheumatoid arthritis. * History of cervical spine surgery. * Pregnancy. * Receipt of physical therapy within the previous 6 months. * History of major psychiatric illness. * Uncontrolled systemic disease, including cardiovascular, pulmonary, hepatic, renal, or hematologic disease. * Uncontrolled systemic endocrine